Annual EBIT
-$104.96 M
+$2.03 M+1.89%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual earnings before interest & taxes is -$104.96 million, with the most recent change of +$2.03 million (+1.89%) on December 31, 2023.
- During the last 3 years, OLMA annual EBIT has fallen by -$83.49 million (-388.92%).
- OLMA annual EBIT is now -4739.14% below its all-time high of -$2.17 million, reached on December 31, 2018.
Performance
OLMA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$37.62 M
-$4.09 M-12.20%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly earnings before interest & taxes is -$37.62 million, with the most recent change of -$4.09 million (-12.20%) on September 30, 2024.
- Over the past year, OLMA quarterly EBIT has dropped by -$14.28 million (-61.17%).
- OLMA quarterly EBIT is now -3599.21% below its all-time high of -$1.02 million, reached on December 31, 2019.
Performance
OLMA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$135.91 M
-$14.28 M-11.74%
September 30, 2024
Summary
- As of February 7, 2025, OLMA TTM earnings before interest & taxes is -$135.91 million, with the most recent change of -$14.28 million (-11.74%) on September 30, 2024.
- Over the past year, OLMA TTM EBIT has dropped by -$34.14 million (-33.55%).
- OLMA TTM EBIT is now -13263.42% below its all-time high of -$1.02 million, reached on December 31, 2019.
Performance
OLMA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OLMA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.9% | -61.2% | -33.5% |
| 3 y3 years | -388.9% | -61.2% | -33.5% |
| 5 y5 years | -4739.1% | -61.2% | -33.5% |
OLMA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | +1.9% | -74.2% | at low | -90.1% | at low |
| 5 y | 5-year | -2331.9% | +1.9% | -3599.2% | at low | <-9999.0% | at low |
| alltime | all time | -4739.1% | +1.9% | -3599.2% | at low | <-9999.0% | at low |
Olema Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.62 M(+12.2%) | -$135.91 M(+11.7%) |
| Jun 2024 | - | -$33.53 M(-2.4%) | -$121.63 M(+10.9%) |
| Mar 2024 | - | -$34.34 M(+12.9%) | -$109.70 M(+4.5%) |
| Dec 2023 | -$104.96 M(-1.9%) | -$30.42 M(+30.3%) | -$104.96 M(+3.1%) |
| Sep 2023 | - | -$23.34 M(+8.1%) | -$101.76 M(+0.1%) |
| Jun 2023 | - | -$21.60 M(-27.0%) | -$101.64 M(-10.3%) |
| Mar 2023 | - | -$29.60 M(+8.8%) | -$113.34 M(+5.9%) |
| Dec 2022 | -$106.99 M | -$27.22 M(+17.2%) | -$106.99 M(+5.4%) |
| Sep 2022 | - | -$23.22 M(-30.2%) | -$101.53 M(+5.7%) |
| Jun 2022 | - | -$33.29 M(+43.2%) | -$96.07 M(+21.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.25 M(+6.9%) | -$79.30 M(+10.9%) |
| Dec 2021 | -$71.49 M(+233.0%) | -$21.76 M(+22.5%) | -$71.49 M(+19.4%) |
| Sep 2021 | - | -$17.76 M(+7.5%) | -$59.87 M(+19.9%) |
| Jun 2021 | - | -$16.52 M(+6.9%) | -$49.95 M(+39.2%) |
| Mar 2021 | - | -$15.45 M(+52.5%) | -$35.88 M(+67.1%) |
| Dec 2020 | -$21.47 M(+397.4%) | -$10.13 M(+29.2%) | -$21.47 M(+73.8%) |
| Sep 2020 | - | -$7.84 M(+219.8%) | -$12.35 M(+173.9%) |
| Jun 2020 | - | -$2.45 M(+135.9%) | -$4.51 M(+119.3%) |
| Mar 2020 | - | -$1.04 M(+2.3%) | -$2.06 M(+102.3%) |
| Dec 2019 | -$4.32 M(+99.0%) | -$1.02 M | -$1.02 M |
| Dec 2018 | -$2.17 M | - | - |
FAQ
- What is Olema Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual EBIT year-on-year change?
- What is Olema Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly EBIT year-on-year change?
- What is Olema Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals TTM EBIT year-on-year change?
What is Olema Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of OLMA is -$104.96 M
What is the all time high annual EBIT for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual earnings before interest & taxes is -$2.17 M
What is Olema Pharmaceuticals annual EBIT year-on-year change?
Over the past year, OLMA annual earnings before interest & taxes has changed by +$2.03 M (+1.89%)
What is Olema Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of OLMA is -$37.62 M
What is the all time high quarterly EBIT for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$1.02 M
What is Olema Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, OLMA quarterly earnings before interest & taxes has changed by -$14.28 M (-61.17%)
What is Olema Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of OLMA is -$135.91 M
What is the all time high TTM EBIT for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high TTM earnings before interest & taxes is -$1.02 M
What is Olema Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, OLMA TTM earnings before interest & taxes has changed by -$34.14 M (-33.55%)